Baicalin: The most abundant flavonoid glycoside in the root; anti-inflammatory, antioxidant, neuroprotective, and antimicrobial; it is a prodrug that is converted to baicalein by intestinal enzymes

Baicalein: The aglycone (active) form of baicalin; a powerful antioxidant with direct GABA receptor activity, anticancer properties, and ability to cross the blood-brain barrier

Wogonin: A flavonoid with anti-inflammatory, anti-allergic, anxiolytic, and neuroprotective properties; inhibits CYP1A2 and CYP2C19 enzymes

Wogonoside: The glycoside form of wogonin

Oroxylin A: A flavonoid with cognitive-enhancing and anti-inflammatory effects

Chrysin: A flavonoid with anxiolytic and aromatase-inhibiting properties

Scutellarin and Scutellarein: Flavonoids found primarily in aerial parts

Inhibits COX-2 (cyclooxygenase-2), reducing inflammatory prostaglandin production, similar to NSAIDs but through natural flavonoid mechanisms

Suppresses NF-kB signaling, a master regulator of inflammatory gene expression

Blocks production of pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6

Inhibits iNOS (inducible nitric oxide synthase), reducing excessive nitric oxide in inflammation

Flavocoxid (a standardized extract of baicalin + catechins) was shown comparable to naproxen for osteoarthritis symptoms in randomized controlled trials

Dual inhibition of both COX and 5-LOX (lipoxygenase) pathways, an advantage over most conventional anti-inflammatory drugs

Baicalin and baicalein cross the blood-brain barrier, providing direct neuroprotection

Protects neurons against glutamate excitotoxicity, oxidative stress, and inflammatory damage

Reduces amyloid-beta aggregation relevant to Alzheimer's disease (baicalin interacts with copper to suppress aggregation)

Protects dopaminergic neurons in Parkinson's disease models

Improves spatial memory and reduces neuroinflammation in chronic cerebral hypoperfusion models

Baicalin is a prolyl oligopeptidase inhibitor, which may enhance cognitive function

Stimulates neurogenesis and promotes neural cell differentiation

Baicalein interacts with GABA-A receptors at non-benzodiazepine binding sites, producing anxiolytic effects without the sedation and addiction risk of benzodiazepines

Wogonin also binds GABA-A receptors and enhances GABAergic signaling

Increases sleep duration in animal models

Clinical research on standardized skullcap extract (300 mg twice daily for 8 weeks) showed significant anxiety reduction in generalized anxiety disorder patients

Traditional use for insomnia, nervous tension, and irritability

Paradoxically, despite rare case reports of liver injury with combination products containing skullcap, isolated baicalin has demonstrated strong hepatoprotective effects in research

Baicalin reduced liver enzyme levels (ALT and AST) by approximately 50% in animal models of liver damage

Protects against alcohol-induced liver damage by reducing oxidative stress and controlling the Shh pathway

Key ingredient in Sho-saiko-to and Yang-Gan-Wan, classical liver-protective herbal formulas

Prevents hepatic fibrosis by suppressing hepatic stellate cell activation

Antibacterial activity against drug-resistant Staphylococcus aureus (MRSA)

Baicalin enhances the effectiveness of conventional antibiotics against resistant bacteria

Antiviral activity against influenza, herpes viruses, and other viral pathogens

Antifungal properties against Candida species

Investigated as a potential therapeutic agent for respiratory infections

Cardiovascular protection: Protects heart cells from ischemia/reperfusion injury; reduces oxidative stress in cardiomyocytes by approximately 50%

Anti-allergic effects: Wogonin suppresses IgE and IL-5 production, relevant to allergic disorders

Anti-cancer properties: Induces apoptosis in various cancer cell lines; studied in prostate, liver, colon, and lung cancers

Blood pressure support: Traditional use for hypertension; pre-hypertensive volunteers showed average 7 mmHg systolic reduction

Blood sugar regulation: Combined with metformin, improved glucose tolerance and gut microbiota in type 2 diabetes patients

Skin health: Baicalein and wogonin protect against UV skin damage; wogonin shows benefits for psoriasis-related inflammation

Anticonvulsant effects: Wogonin demonstrated anticonvulsant activity in animal models

Standard TCM dose: 3-9 grams daily, typically as part of an herbal combination formula

Decoction (tea): 3-9 grams of dried root simmered in water for 20-30 minutes; divided into 2-3 doses daily

Single herb use: Less common in TCM; most traditional formulas combine Huang-Qin with other herbs

General anti-inflammatory/antioxidant support: 250-500 mg daily of standardized extract

Anxiety and sleep support: 300 mg twice daily (600 mg total) of standardized extract

Standardized to baicalin: Look for extracts containing 50% or higher baicalin content

Starting dose: 250 mg once daily for the first 3-7 days to assess tolerance

Maintenance dose: 500 mg, 1-2 times daily

Studied range: 200-800 mg daily in most supplement formulations

Phase 1 safety study: Baicalein doses from 100 mg to 2,800 mg showed no liver or kidney toxicity in healthy volunteers

Typical supplement dose: 100-500 mg daily

Note: Baicalein has very low oral bioavailability (approximately 95% is metabolized, with only about 5% remaining unchanged in circulation); however, its metabolites are biologically active

Osteoarthritis: 250-500 mg tablets, as previously prescribed (note: flavocoxid was withdrawn from the US market in 2017 due to efficacy questions, not safety)

Clinical trials providing firm dosing recommendations are lacking for Baical Skullcap as a standalone supplement

Most traditional use involves combination formulas rather than isolated use

Start low and increase gradually, especially given rare liver injury reports

Consider working with a practitioner experienced in Chinese herbal medicine for traditional formulations

For anxiety/calming effects: Late afternoon or evening; baicalein's GABA activity may promote relaxation

For sleep support: 30-60 minutes before bedtime

For anti-inflammatory benefits: Divided doses morning and evening for sustained levels

For general health: With meals, divided into 2 doses daily

With food is recommended: Reduces potential for digestive discomfort, which is the most common side effect

Fat-containing meals: May improve absorption of the lipophilic flavonoids (baicalein, wogonin)

Avoid taking with dairy: Tannins in skullcap root can bind to proteins and reduce absorption

Baicalin (the glycoside form) has low direct absorption; it must be converted to baicalein by intestinal enzymes (beta-glucuronidase) before it can be absorbed into the bloodstream

Once absorbed, baicalein is rapidly converted back to baicalin and other metabolites in the liver

This means gut health and microbiome composition directly influence how effectively you metabolize and benefit from Baical Skullcap

Baicalein itself has poor oral bioavailability, but its metabolites retain biological activity

Peak plasma levels of baicalin metabolites occur approximately 1-2 hours after oral administration

Long-term continuous use data is limited for standalone skullcap supplements

A conservative approach would be cycling: 8-12 weeks on, 2-4 weeks off

In traditional Chinese medicine, Huang-Qin is often used in formula for defined treatment periods rather than indefinitely

Monitor liver function if using for extended periods (see Special Considerations)

Anti-anxiety effects: May be noticeable within 30-60 minutes (GABA receptor activity)

Anti-inflammatory benefits: Typically 1-4 weeks of regular use

Neuroprotective effects: Long-term benefits; likely requires weeks to months

Sleep quality improvement: Often within the first 1-2 weeks

GABA-A receptor modulation: Baicalein and wogonin bind to GABA-A receptors at non-benzodiazepine sites, enhancing the brain's primary inhibitory (calming) neurotransmitter system without the addiction risk associated with benzodiazepine drugs; this produces anxiolytic and sleep-promoting effects

Dual COX/LOX inhibition: Flavonoids inhibit both cyclooxygenase (COX-1 and COX-2) and 5-lipoxygenase (5-LOX) pathways, blocking the conversion of arachidonic acid into inflammatory prostaglandins and leukotrienes; this dual inhibition is more comprehensive than most NSAIDs which only target COX

NF-kB suppression: Blocks nuclear factor kappa-B signaling, reducing transcription of inflammatory genes and cytokine production

Free radical scavenging: Baicalein and baicalin directly neutralize hydroxyl, DPPH, and alkyl radicals with IC50 values of 10-32 micromolar

Amyloid-beta interaction: Baicalin chelates copper ions and directly interacts with amyloid-beta peptides, inhibiting their aggregation (a key pathological process in Alzheimer's disease)

HSP70 induction: Activates heat shock protein 70, a cellular stress response protein that protects neurons from damage

CYP enzyme modulation: Wogonin inhibits CYP1A2 and CYP2C19; baicalin affects organic anion transport polypeptides (OATPs), which impacts the absorption and metabolism of certain drugs

Prolyl oligopeptidase inhibition: Baicalin inhibits this enzyme in the central nervous system, which may enhance memory and cognitive function

Epigenetic modulation: Baicalin suppresses Wnt signaling and derepresses PPAR-gamma in hepatic stellate cells, preventing liver fibrosis through epigenetic mechanisms

Magnesium: Complementary GABA support; enhances calming effects; recommended for anxiety and sleep protocols

L-Theanine: Additional GABA modulation and alpha brain wave promotion; synergistic for relaxation without sedation

Ashwagandha: Adaptogenic stress support; complementary anxiolytic pathway (ashwagandha works via cortisol modulation while skullcap works via GABA)

Probiotics: Gut bacteria are essential for converting baicalin to its active form baicalein; healthy microbiome enhances effectiveness

Omega-3 fish oil: Complementary anti-inflammatory support through different pathways

Curcumin/Turmeric: Synergistic NF-kB suppression and anti-inflammatory activity

Vitamin D: Combined immune modulation and anti-inflammatory support

Milk Thistle (Silymarin): Complementary liver protection; may offset any hepatic concerns

Bupleurum (Chai Hu): Traditional TCM pairing in Xiao Chai Hu Tang formula; liver and immune support

Anxiety/sleep protocol: Baical Skullcap + magnesium glycinate + L-theanine + passionflower

Anti-inflammatory stack: Baical Skullcap + curcumin + omega-3 + boswellia

Neuroprotective protocol: Baical Skullcap + lion's mane + omega-3 + vitamin D

Allergy support: Baical Skullcap + quercetin + vitamin C + stinging nettle

Liver support: Baical Skullcap + milk thistle + NAC (N-acetyl cysteine)

Cyclosporine: Animal studies found baicalin markedly reduced cyclosporine absorption; individuals taking cyclosporine for organ transplant rejection should NOT use Baical Skullcap

Warfarin and blood thinners: Lab studies show baicalin has antithrombotic activity; combining may increase bleeding risk; clinical significance not fully established but caution is strongly warranted

Statins (Rosuvastatin, Atorvastatin, Simvastatin): Baicalin decreased blood levels of statin drugs in healthy volunteers by affecting OATP1B1 transport; this could reduce statin effectiveness

CYP1A2 substrates: Wogonin inhibits CYP1A2 in vitro; drugs metabolized by this enzyme include caffeine, theophylline, clozapine, and some antidepressants

CYP2C19 substrates: Wogonin also inhibits CYP2C19; drugs affected include omeprazole, clopidogrel, and some antiepileptics

Sedative medications (benzodiazepines, sleep aids): Additive sedation through GABA enhancement; may cause excessive drowsiness

Blood pressure medications: Potential additive blood pressure-lowering effects

Anticoagulant/antiplatelet drugs: Potential additive effects on bleeding risk beyond warfarin

Other hepatotoxic drugs or supplements: Given rare liver injury reports, avoid stacking with other potentially hepatotoxic agents (high-dose acetaminophen, kava, germander, high-dose green tea extract)

SLC transporter substrates: Baicalein, baicalin, and wogonin inhibited solute carrier transporters in vitro, potentially affecting cellular uptake of various drugs

Most interaction data comes from in vitro (test tube) or animal studies; clinical relevance in humans is not fully established for many interactions

The statin interaction (reduced blood levels) is the best-documented human interaction

When in doubt, separate Baical Skullcap from medications by at least 2-4 hours and consult your healthcare provider

Individuals seeking natural anti-inflammatory support, particularly for joint discomfort

People dealing with anxiety, stress, or difficulty sleeping who want a non-habit-forming alternative

Those interested in neuroprotective support and long-term brain health

Individuals with chronic low-grade inflammation contributing to overall health concerns

People looking for natural allergy support

Those interested in antimicrobial support, especially during cold and flu season

Individuals wanting antioxidant protection with a 2,000+ year track record in traditional medicine

People exploring natural options for blood pressure or blood sugar support as a complement to medical care

Adults with mild to moderate anxiety not currently on prescription anxiolytics

Individuals with osteoarthritis seeking natural anti-inflammatory alternatives

Men and women concerned about age-related cognitive decline

People with allergies or histamine sensitivity

Those following an integrative medicine approach under practitioner guidance

Organ transplant recipients on cyclosporine: Potentially dangerous reduction in drug absorption

Individuals with active liver disease or a history of drug-induced liver injury: Given rare but documented liver injury reports with combination products

People with known allergy to Lamiaceae (mint family) plants: Cross-reactivity is possible

People taking blood thinners (Warfarin, Heparin, Plavix): Potential additive anticoagulant effects

Those on statin medications: Baicalin may reduce statin blood levels and effectiveness

Individuals taking sedative or CNS-depressant medications: Additive sedation risk

Pregnant women: Safety in pregnancy has not been established; traditionally used with caution in TCM pregnancy formulas; avoid without practitioner guidance

Breastfeeding women: Insufficient safety data; avoid

Children: Safety not established; adult-only use recommended unless under practitioner supervision

People with severe kidney disease: Insufficient safety data

Those scheduled for surgery: Discontinue at least 2 weeks before surgery due to potential blood-thinning effects

Liver function (ALT, AST) if using for more than 8-12 weeks continuously

Blood pressure if combining with antihypertensive medications

Sedation levels, particularly when starting or when combining with other calming supplements

Drug levels if taking medications with narrow therapeutic windows

Potent dual COX/LOX anti-inflammatory activity demonstrated in both laboratory and clinical settings

Flavocoxid (baicalin-based product) shown comparable to naproxen for osteoarthritis symptoms in randomized controlled trials

Strong neuroprotective effects across multiple in vitro and in vivo models of neuronal injury

GABA receptor modulation confirmed for anxiolytic and sedative effects

Antimicrobial activity including enhancement of antibiotic effectiveness against drug-resistant bacteria

Antioxidant capacity with IC50 values demonstrating potent free radical scavenging

Over 2,000 years of traditional use with a generally favorable safety profile

Phase 1 safety study showed no liver or kidney toxicity with baicalein doses up to 2,800 mg

Hepatoprotective effects of isolated baicalin confirmed in multiple models of liver injury

Preliminary human data supporting benefits for glucose tolerance when combined with metformin

Reduced anxiety and improved emotional baseline without the addiction risk of benzodiazepines

Better sleep quality and easier sleep onset

Reduced joint pain and stiffness for those with inflammatory conditions

Immune support during cold and flu season

Comprehensive anti-inflammatory coverage through dual COX/LOX inhibition

Long-term brain health support through multiple neuroprotective mechanisms

Drowsiness or sedation (particularly at higher doses or when combined with other calming agents)

Digestive discomfort, bitter taste

Possible mild GI upset when taken on an empty stomach

Liver injury (rare but documented): Case reports of acute liver injury have been associated with products containing Baical Skullcap, particularly the combination product Move Free Advanced (which contains Chinese skullcap + black catechu) and flavocoxid (baicalin + catechins). Important context: in every published case report, the patient was concurrently taking at least one other supplement with an established association with liver damage. A prospective study specifically testing whether long-term Baical Skullcap supplementation alone causes liver dysfunction found no evidence of hepatotoxicity. Nevertheless, monitoring liver enzymes with long-term use is prudent.

Pneumonitis: Rare reports of lung inflammation associated with skullcap-containing preparations (Ou-gon)

Elevated CRP and triglycerides: In one study of healthy subjects, baicalein tablets were possibly associated with elevated high-sensitivity CRP and triglycerides

Fever: Rare side effect reported with Baical Skullcap use

Some early liver injury cases attributed to "skullcap" may have actually been caused by adulteration with germander (Teucrium), a known hepatotoxin that was sometimes substituted for skullcap

Quality control varies between manufacturers; third-party testing is important

American Skullcap and Chinese Skullcap are sometimes confused or mislabeled in products

Ensure the product specifies Scutellaria baicalensis (root) if seeking Chinese Skullcap's effects

Chronic inflammation or elevated inflammatory markers

Anxiety, nervous tension, or difficulty calming the mind

Insomnia or poor sleep quality

Joint pain and stiffness, particularly from osteoarthritis

Frequent infections or susceptibility to colds and flu

Allergic conditions including seasonal allergies and histamine sensitivity

Oxidative stress from environmental exposures, aging, or lifestyle factors

Concerns about cognitive decline or neurodegeneration

Skin conditions worsened by inflammation (psoriasis, eczema)

Persistent low-grade inflammation that conventional anti-inflammatories only partially address

Anxiety that doesn't warrant prescription medication but still impacts quality of life

Difficulty winding down in the evening or mind racing at bedtime

Joint discomfort that worsens with age or activity

Interest in a natural antimicrobial and immune support option

Family history of neurodegenerative conditions (Alzheimer's, Parkinson's)

Desire for a traditional herbal anti-inflammatory with modern scientific backing

Baical Skullcap has a generally favorable safety profile at recommended doses

Phase 1 safety data: Baicalein at doses from 100 mg to 2,800 mg showed no liver or kidney toxicity in healthy volunteers

In 1,005 patients treated with flavocoxid in an open-label study, only one had liver test abnormalities

Among 300 cases of drug-induced liver disease in a US prospective study (2004-2008), none were attributed to flavocoxid

Repeated high-dose administration in animal studies did not show toxicity at standard supplemental levels

Jaundice (yellowing of skin or eyes) - stop immediately and seek medical attention

Dark urine or pale stools - potential sign of liver stress

Unexplained nausea, abdominal pain, or loss of appetite

Unusual fatigue or malaise

Fever or respiratory symptoms (potential pneumonitis - extremely rare)

Excessive bruising or bleeding (potential anticoagulant effect)

The root is the medicinal part and is generally safe at recommended doses

No specific toxic alkaloids in the root at standard supplemental doses

The aerial parts (leaves/flowers) contain different flavonoid profiles and are not interchangeable with the root

Discontinue use immediately

Seek medical evaluation with liver function tests

All documented cases of liver injury resolved after stopping the supplement

No cases of acute liver failure have been linked to Baical Skullcap or flavocoxid

Rechallenge (restarting after a reaction) should be avoided

Standardized root extract capsules: Most common supplement form; look for standardization to baicalin (minimum 50%) or total flavonoids; provides consistent dosing

Dried root for decoction: Traditional TCM method; provides the full spectrum of compounds; bitter taste is characteristic and considered therapeutically meaningful in TCM

Tincture (alcohol extract): Provides good extraction of flavonoids; alcohol content may be a consideration for some users

Combination formulas: In TCM, Huang-Qin is almost always used in multi-herb formulas rather than alone; classical formulas have centuries of clinical use data

Isolated baicalin or baicalein supplements: Available for targeted use; baicalin is more commonly supplemented due to its stability

Scutellaria baicalensis (Baical/Chinese): Uses the ROOT; primary compounds are baicalin, baicalein, wogonin; stronger anti-inflammatory, antimicrobial, and anticancer properties; more extensively studied scientifically

Scutellaria lateriflora (American): Uses the AERIAL parts (leaves/stems); primary compounds include scutellarin and other flavonoids; traditionally used more specifically for nervousness, anxiety, and muscle tension; fewer large-scale studies

Always check the species and plant part listed on the supplement label

The liver injury concern is the single most important safety consideration for this herb

Context matters: All published liver injury cases involved combination products, and patients were taking other potentially hepatotoxic agents concurrently

Isolated baicalin has shown hepatoprotective (liver-protecting) properties in research

Practical steps: Get baseline liver enzymes before starting; retest after 4-8 weeks; avoid combining with other potentially hepatotoxic supplements (kava, high-dose green tea extract, comfrey); avoid excessive alcohol use while supplementing; discontinue and get tested if any symptoms of liver stress develop

Choose reputable brands with third-party testing and clear species identification

Similar to pomegranate, your gut bacteria play a critical role in activating Baical Skullcap's compounds

Baicalin must be converted to baicalein by intestinal beta-glucuronidase enzymes (produced by gut bacteria) before absorption

Supporting a healthy gut microbiome with probiotics, prebiotics, and fiber-rich foods may enhance the herb's effectiveness

Anti-inflammatory activity through dual COX/LOX inhibition (extensive laboratory and animal data; some human clinical data)

Antioxidant capacity of baicalin, baicalein, and wogonin (well-characterized in vitro)

GABA receptor activity of baicalein and wogonin (confirmed binding studies)

Neuroprotective effects in multiple models of neuronal injury (robust preclinical data)

Phase 1 safety of baicalein up to 2,800 mg (human data)

Antimicrobial activity including antibiotic enhancement (laboratory confirmed)

Osteoarthritis symptom relief (randomized controlled trials with flavocoxid, though the product was withdrawn)

Anxiety reduction (one clinical study with promising results; traditional use evidence)

Hepatoprotective effects of isolated baicalin (strong animal data; limited human data)

Blood pressure reduction (small human studies; traditional use)

Glucose tolerance improvement in combination with metformin (preliminary human data)

Anti-allergic effects via IgE and IL-5 suppression (animal models)

Alzheimer's disease prevention or treatment (strong mechanistic data but no human clinical trials)

Parkinson's disease neuroprotection (animal models only)

Cancer treatment or prevention (in vitro and animal data; no clinical trials for standalone use)

Sleep quality improvement (traditional use; limited clinical data specific to Baical Skullcap)

Antiviral effectiveness in clinical settings (laboratory data promising; human data lacking)

Psoriasis treatment (case report level evidence)

Very few high-quality, standalone clinical trials for Baical Skullcap or its isolated compounds

Most human studies involve multi-herb formulas, making it difficult to attribute effects to Baical Skullcap specifically

Optimal dosing for specific conditions has not been established

Long-term safety data for isolated use is limited

More human pharmacokinetic studies are needed to understand bioavailability and metabolism